Mesenchymal Stem Cells for Vascular Regeneration
- 23 October 2008
- journal article
- review article
- Published by Informa UK Limited in Regenerative Medicine
- Vol. 3 (6), 877-892
- https://doi.org/10.2217/17460751.3.6.877
Abstract
Mesenchymal stem cells (MSCs) have tremendous potential for regenerative medicine, and have been researched for the treatment of cardiovascular diseases. MSCs are a promising cell type because of their ease of isolation and expansion, their multipotency and their low immunogenicity. However, in order to fully utilize the therapeutic potential of MSCs, it is important to understand the intrinsic property of MSCs and the role of the microenvironment in modulating MSC behavior and function. Microenvironmental factors such as mechanical cues, soluble factors and matrix properties not only regulate MSC differentiation, but also modulate MSC signaling to the surrounding environment. Understanding the properties of MSCs and the role of the microenvironment will be beneficial for developing in vivo therapies for the construction of tissue-engineered vascular grafts and the treatment of ischemic cardiac tissues.Keywords
Funding Information
- National Institute of Health (HL HL078534, HL083900)
This publication has 137 references indexed in Scilit:
- Small‐diameter human vessel wall engineered from bone marrow‐derived mesenchymal stem cells (hMSCs)The FASEB Journal, 2008
- Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular graftsProceedings of the National Academy of Sciences of the United States of America, 2007
- Vascular endothelial growth factor can signal through platelet-derived growth factor receptorsThe Journal of cell biology, 2007
- Engineering of Vascular Grafts With Genetically Modified Bone Marrow Mesenchymal Stem Cells on Poly (Propylene Carbonate) GraftArtificial Organs, 2006
- Anisotropic mechanosensing by mesenchymal stem cellsProceedings of the National Academy of Sciences of the United States of America, 2006
- Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose TissueThe International Journal of Cell Cloning, 2006
- Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarctionNature Medicine, 2006
- VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cellsBiochemical and Biophysical Research Communications, 2005
- Pluripotency of mesenchymal stem cells derived from adult marrowNature, 2002
- The Role of Fluid Mechanics in the Localization and Detection of AtherosclerosisJournal of Biomechanical Engineering, 1993